Andrew Serafin
2021
In 2021, Andrew Serafin earned a total compensation of $570.9K as EVP and Chief Strategy Officer at Harmony Biosciences Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $192,418 |
|---|---|
| Salary | $366,510 |
| Other | $11,991 |
| Total | $570,919 |
Serafin received $366.5K in salary, accounting for 64% of the total pay in 2021.
Serafin also received $192.4K in non-equity incentive plan and $12K in other compensation.
Rankings
In 2021, Andrew Serafin's compensation ranked 10,433rd out of 12,415 executives tracked by ExecPay. In other words, Serafin earned more than 16.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,433 out of 12,415 | 16th |
Division Manufacturing | 4,619 out of 5,505 | 16th |
Major group Chemicals And Allied Products | 2,069 out of 2,375 | 13th |
Industry group Drugs | 1,835 out of 2,096 | 13th |
Industry Pharmaceutical Preparations | 1,361 out of 1,546 | 12th |
Source: SEC filing on April 8, 2022.
Serafin's colleagues
We found five more compensation records of executives who worked with Andrew Serafin at Harmony Biosciences Holdings in 2021.
2021
Sandip Kapadia
Harmony Biosciences Holdings
Chief Financial Officer
2021
Jeffrey Dierks
Harmony Biosciences Holdings
EVP and Chief Commercial Officer
2021
John Jacobs
Harmony Biosciences Holdings
Chief Executive Officer
2021
Jeffrey Dayno
Harmony Biosciences Holdings
Chief Medical Officer
2021
Susan Drexler
Harmony Biosciences Holdings